StonvexLoading…
StonvexStonvexStonvexCore line items from SVV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $403.19M | $1.68B | $1.21B | $787.35M |
Operating Income | $12.45M | $124.10M | $80.77M | $44.42M |
Net Income | $-5.26M | $22.64M | $191.00K | $14.19M |
EPS (Diluted) | $-0.03 | $0.14 | $0.00 | $0.09 |
Total Assets | $2.02B | $2.01B | $1.96B | $1.94B |
Total Liabilities | $1.59B | $1.58B | $1.55B | $1.52B |
Cash & Equivalents | $61.61M | $85.90M | $63.52M | $70.55M |
Free Cash Flow OCF − CapEx | $-9.86M | $48.64M | $-4.59M | $1.72M |
Shares Outstanding | 154.70M | 155.28M | 156.22M | 155.40M |